Products & Solutions
Science from Nature, Solutions for Tomorrow. 
Filter:
[en]AKNUTR® [/en]Nutrition
[en]AKCOS® [/en]Personal Care
[en]AKTINPHARM® [/en]Pharmaceutical
APIs & Intermediates
[en]AkVEri® [/en]Life Science Reagents
Intermediates

                    
Current Filters261Product
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

Cat. No.

AKA-162

CAS No.

150728-13-5

MF

C15H10Cl2N4O2

MW

349.2

4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine is a heterocyclic compound based on a bipyrimidine scaffold with a 2-methoxyphenoxy substituent, used as an intermediate in heterocyclic synthesis.
Sodium Cholate

Cat. No.

AKA-163

CAS No.

361-09-1

MF

C24H39NaO5

MW

430.6

Cholic acid sodium is the primary bile acid produced in the liver, typically conjugated with glycine or taurine, which facilitates fat absorption and cholesterol excretion.
MBTH hydrochloride Hydrate

Cat. No.

AKA-164

CAS No.

38894-11-0

MF

C8H12ClN3OS

MW

233.72

3-Methyl-2-benzothiazolinone hydrazone hydrochloride hydrate (MBTH) is a hydrazone-containing colorimetric reagent widely used in the spectrophotometric determination of aldehydes and phenolic compounds.
Ferrocene

Cat. No.

AKA-165

CAS No.

102-54-5

MF

C10H10Fe

MW

186.03

Ferrocene is an important structural core in bioorganometallic chemistry because of its inherent stability, excellent redox properties and low toxicity.
Emodin

Cat. No.

AKA-166

CAS No.

518-82-1

MF

C15H10O5

MW

270.2369

Emodin is an anthraquinone derivative that acts as a potent and selective 11β-HSD1 inhibitor and also inhibits casein kinase 2 (CK2).
4-(Aminomethyl)benzoic Acid

Cat. No.

AKA-167

CAS No.

56-91-7

MF

C8H9NO2

MW

151.16

4-(Aminomethyl)benzoic acid is a competitive inhibitor of PepT1 and has antifibrinolytic activity.
3-Cyanopyridine

Cat. No.

AKA-168

CAS No.

100-54-9

MF

C6H4N2

MW

104.11

3-Cyanopyridine is a heterocyclic compound bearing a nitrile group at the 3-position of the pyridine ring and is an important intermediate for the synthesis of niacin analogues and other pyridine derivatives.
Shikimic Acid

Cat. No.

AKA-169

CAS No.

138-59-0

MF

C7H10O5

MW

174.1513

Shikimic acid is a key metabolic intermediate of the aromatic amino acid biosynthesis pathway.
Gossypol Acetate

Cat. No.

AKA-170

CAS No.

12542-36-8

MF

C32H34O10

MW

578.60636

Gossypol acetic acid binds to Bcl-xL protein and Bcl-2 protein.
Potassium Pyrosulfate

Cat. No.

AKA-171

CAS No.

7790-62-7

MF

K2O7S2

MW

254.33

Potassium pyrosulfate is a kind of biological materials or organic compounds that are widely used in life science research.
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH

Cat. No.

AKA-175

CAS No.

2460751-66-8

MF

C66H105N5O16

MW

1224.57

The tirzepatide side chain is an Fmoc-protected lysine derivative bearing a C20 diacid, glutamate and two AEEA linkers, used in the solid-phase synthesis of the tirzepatide peptide.
(1R,2R)-1,2-Cyclohexanedimethanol

Cat. No.

AKA-176

CAS No.

65376-05-8

MF

C8H16O2

MW

144.21

(1R,2R)-1,2-Cyclohexanedimethanol is a chiral diol with trans configuration, commonly used as a chiral building block and ligand precursor in asymmetric synthesis, and is an intermediate of Lurasidone Hydrochloride.
4-(1,2-Benzisothiazol-3-yl)-1-piperazine

Cat. No.

AKA-177

CAS No.

87691-87-0

MF

C11H13N3S

MW

219.31

3-(1-Piperazinyl)-1,2-benzisothiazole is a heterocyclic organic compound containing both a piperazine ring and a benzisothiazole ring, commonly used as an intermediate in fine chemicals and heterocyclic compound synthesis.
3-Piperazinyl-1,2-Benzisothiazole Hydrochloride

Cat. No.

AKA-178

CAS No.

87691-88-1

MF

C11H14ClN3S

MW

255.77

3-Piperazinyl-1,2-benzisothiazole hydrochloride is the monohydrochloride salt form of the corresponding piperazine–benzisothiazole free base, used as an intermediate in heterocyclic organic synthesis.
3-Piperazinyl-1,2-Benzisothiazole Hydrochloride

Cat. No.

AKA-180

CAS No.

144010-02-6

MF

C11H14ClN3S

MW

255.77

3-Piperazinyl-1,2-benzisothiazole hydrochloride is a hydrochloride salt form of the corresponding piperazine–benzisothiazole free base, used as an intermediate in heterocyclic organic synthesis.
Tabersonine Hydrochloride

Cat. No.

AKA-184

CAS No.

29479-00-3

MF

C21H25ClN2O2

MW

372.9

Tabersonine hydrochloride is a selective, active NLRP3 inhibitor that directly binds to the NACHT domain of NLRP3, inhibiting its ATPase activity and oligomerization.
Cart
TotalProducts
Request Quote
  • China
  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Central African Republic
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Côte d'Ivoire
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor (Timor-Leste)
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Greece
  • Grenada
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • South Korea
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar (Burma)
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sri Lanka
  • Sudan
  • South Sudan
  • Suriname
  • Sweden
  • Switzerland
  • Syria
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates (UAE)
  • United Kingdom (UK)
  • United States (US)
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Yemen
  • Zambia
  • Zimbabwe
  • Beijing-Beijing
  • Tianjin-Tianjin
  • Hebei-Shijiazhuang
  • Shanxi-Taiyuan
  • Inner Mongolia-Hohhot
  • Liaoning-Shenyang
  • Jilin-Changchun
  • Heilongjiang-Harbin
  • Shanghai-Shanghai
  • Jiangsu-Nanjing
  • Zhejiang-Hangzhou
  • Anhui-Hefei
  • Fujian-Fuzhou
  • Jiangxi-Nanchang
  • Shandong-Jinan
  • Henan-Zhengzhou
  • Hubei-Wuhan
  • Hunan-Changsha
  • Guangdong-Guangzhou
  • Guangxi-Nanning
  • Hainan-Haikou
  • Chongqing-Chongqing
  • Sichuan-Chengdu
  • Guizhou-Guiyang
  • Yunnan-Kunming
  • Tibet-Lhasa
  • Shaanxi-Xi'an
  • Gansu-Lanzhou
  • Qinghai-Xining
  • Ningxia-Yinchuan
  • Xinjiang-Urumqi
  • Hong Kong-Hong Kong
  • Macao-Macao
  • Taiwan-Taipei